SCM
KALA icon

Symons Capital Management’s KALA BIO KALA Stock Holding History

Symons Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$37K Hold
6
– – 0.02% 71
2021
Q2 		$79K Hold
6
– – 0.05% 72
2021
Q1 		$100K Buy
+6
New +$117K 0.05% 86

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Symons Capital Management's KALA Position: Q3 2021 in Review

Symons Capital Management held its KALA BIO (KALA) position steady in Q3 2021 at 6 shares worth $37K. The position accounts for 0.02% of the portfolio, ranked #71.

Symons Capital Management first reported a position in KALA in Q1 2021 and has held it in 3 quarters since. The position peaked at $100K in Q1 2021. 99 funds tracked by Wall St. Rank hold KALA as of Q3 2021.

  • Symons Capital Management held 6 shares of KALA BIO worth $37K as of Q3 2021.
  • Symons Capital Management left its KALA BIO share count unchanged in Q3 2021.
  • KALA BIO made up 0.02% of Symons Capital Management's portfolio in Q3 2021, its #71 holding.
  • Symons Capital Management first reported a position in KALA BIO in Q1 2021 and has held it in 3 quarters since.
  • Symons Capital Management's KALA BIO position peaked at $100K in Q1 2021.
  • 99 funds tracked by Wall St. Rank held KALA BIO as of Q3 2021.

Based on Symons Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.